TB epidemiology in Bulgaria

Slides:



Advertisements
Similar presentations
Overview of current case and treatment outcome definitions Malgosia Grzemska TB Operations and Coordination Stop TB Department Consultation Impact of WHO-endorsed.
Advertisements

World Health Organization TB Case Definitions
International Standards of Tuberculosis Care Implementation by Pulmonologists in Private Practice in Jakarta E. Burhan 1, M. A. Nawas 1, D. Kusumo Sutoyo.
Dr R.Reesaul Chest Physician Chest Clinic P. D`or Hospital
Monitoring and Evaluation: A Review of Terms. Goals To provide better treatment for people with tuberculosis in Country X To achieve a treatment success.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
Three key messages on tuberculosis control World Tuberculosis Day 2010 ECDC TB Team European Centre for Disease Prevention and Control Stockholm, 24 March.
Extrapulmonary Site 2 :_____________________ Name (surname, first name) Age (in years) Sex F Alternative address Physical Address (in full) M INTERIM TUBERCULOSIS.
Unit 12: Reporting & Recording Botswana National Tuberculosis Programme Manual Training for Medical Officers.
Monitoring Process of the National TB Control Program (NTP) in the Philippines Anna Marie Celina G. Garfin, MD Medical Specialist IV National Center for.
NATIONAL TB 2012 INDICATOR ANALYSIS REPORT Presented by: Sandile Ginindza Lugogo Sun Hotel 05 th -7 th June 2013 Ministry of Health NTCP.
Extrapulmonary Site 2 :_____________________ TUBERCULOSIS TREATMENT CARD BOTSWANA NATIONAL TUBERCULOSIS PROGRAMME Date RegisteredIN ToOUT RegisteredIN.
Tuberculosis control in Suriname Situational analysis.
1 Identifying Contribution of Community-based DOTS in Treatment Outcome of TB Patients in Four Provinces of Afghanistan Qader, Ghulam MD, DPH, MPH Senior.
Exercise on TB clinical epidemiology: what are the indicators suggesting? G.B. Migliori WHO Collaborating Centre for Control of TB and Lung Diseases,
Looking into the mirror of tuberculosis Supervisors’ meeting Vilnius, Lithuania, May 20, 2005 Slightly modified before meeting in the Directory of Health.
Increasing Tuberculosis Prevalence in South African Township Associated With Increasing HIV Prevalence Slideset on: Lawn SD, Bekker LG, Middelkoop K, Myer.
PMDT in Japan June 2016 Takashi Yoshiyama. Proportion of drug resistance, Japan (Ryoken sampling survey) Without treatment
Antituberculous treatment.
TUBERCULOSIS IN JAPAN ANNUAL REPORT – 2016.
Monitoring and Evaluation Frameworks
Philippe Glaziou Geneva, 12 October 2009
Free State TB Information
Fifth Pacific Stop TB meeting Fiji Islands, May 4-7, 2010
MDR-TB Update Dr Kelvin Charambira
Daffodil International University (DIU), Dhaka Bangladesh
Thyroid Cancer Survival – Population based study – EUROCARE-5
PAEDIATRIC TUBERCULOSIS MAY STILL BE UNDER DIAGNOSED AND UNDER TREATED
PROGRESS IN GLOBAL TB CONTROL
World Tuberculosis Day 2015
© The Author(s) Published by Science and Education Publishing.
The burden of TB in the Western Pacific
Mean annual percentage change in TB notification rates,
Tuberculosis situation in the EU/EEA, 2016
E. Svensson, J. Millet, A. Lindqvist, M. Olsson, M. Ridell, N. Rastogi 
Nino Mdivani NTP of Georgia
TUBERCULOSIS SURVEILLENCE KENYA
Dr. Joseph Bana-Koiri Dr. Gilbert Hiawalyer Papua New Guinea
Characteristics LAM Results Total (%) Statistic P-Value Positive (%)
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
FRANCIS GAUSI and THOMAS NYIRENDA MALAWI.
Tuberculosis in Wales Annual Report 2018 Data to the end of 2017
Buhera District.
SURVEILLANCE AND EPIDEMIOLOGY OF TUBERCULOSIS IN FIJI
TB epidemiological situation in Kyrgyzstan
WS on Surveillance & Epidemiology
Success and failure in TB surveillance in Hungary
National Cancer Statistics in Korea, 2015
Goal Objectives Expected Outcomes
DOTS IMPACT TO TUBERCULOSIS IN LITHUANIA
Cheng shiming National TB Center in China May,3, 2004
Tuberculosis in Slovakia
Surveillance of Tuberculosis
National Tuberculosis Control Program in Vietnam
EXERCISE 11: Computing and Analyzing Program Indicators
SLOVENIA.
Epidemiology of Tuberculosis in Hong Kong
Country Presentation on Analysis of Korea
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
TB notification in Hong Kong
Further explorations of surveillance data
Country presentation Dr.Vija Riekstina National TB registry
Further explorations of surveillance data
Tuberculosis situation in the EU/EEA, 2017
Further explorations of surveillance data
Tuberculosis situation in the EU/EEA, 2017
Community Pharmacists Monitoring of Pulmonary Tuberculosis Outpatients (Preliminary Study)
Tuberculosis in Wales Annual Report 2017 Data to the end of 2016
Tuberculosis situation in the EU/EEA, 2017
RELAPSE İN DRUG-SENSİTİVE PULMONARY TB PATİENTS
Presentation transcript:

TB epidemiology in Bulgaria D. Stefanova V. Ljokova

Republic of Bulgaria Till end of 2001- 7,845,499 population Males- 3,816,200; Females- 4,029,700

TB in Bulgaria 2002 Notification cases- 3,335 with pulmonary TB- 2,942 (88.2 %) with extrapulmonary TB- 393 (11.8 %) Smear positive cases- 1,007 (30.2 %) Smear negative cases- 2,328 (69.8 %) Culture positive cases- 1,253 (37.6 %) Relapses- 373 (11.2 %)

TB incidence in Bulgaria (per 100,000 population)

TB incidence in Bulgaria by counties 1999-2002

Registered TB patients in Bulgaria by counties 2002

Smear positive patients in Bulgaria (per 100,000 population)

Distribution of the registered TB patients in Bulgaria for 2002 by localization

Distribution of the registered TB patients in Bulgaria for 2002 by TB form

Distribution of the registered TB patients in Bulgaria (n=3,335) for 2002 by sex

Distribution of the registered TB patients in Bulgaria (n=3,335) for 2002 by age

Distribution of the registered TB patients in Bulgaria (n=3,335) for 2002 by sex and age

DOTS- outcome of treatment (1075 patients) 2% 7 14% 3 6% 12 25% 26 53% Relapses 49 patients 6 1% 15 3% 494 93% Smear (-) 530 patients 9 14 20 4% 44 9% 394 79% Smear (+) 496 patients Transferred Defaulted Failure Died Treatment completed Cured

DOTS- outcome of treatment- 496 smear positive patients

DOTS- outcome of treatment- 530 smear negative patients

DOTS- outcome of treatment- 49 relapses